ClinicalTrials.Veeva

Menu

POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

UCB logo

UCB

Status and phase

Completed
Phase 4

Conditions

Seasonal Allergic Rhinitis

Treatments

Drug: Levocetirizine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00160537
POPULAR
EudraCT 2004-002971-18
A00391

Details and patient eligibility

About

Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical history of SAR known and treated since 2 years.
  • Positive skin prick test (wheal > 3 mm larger than the diluent control) or RAST (≥3.5 IU/ml) to grass pollen (less than 1 year).
  • Minimum mean T5SS of 8 during the baseline period.

Exclusion criteria

  • Have an associated asthma requiring a daily treatment other than β2 short acting agonist prn
  • Have atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids and any other disease requiring the administration of oral or topical corticosteroids

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems